Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

JUPITER II: Double blind randomised comparison of JANUS Tacrolimus-eluting stent with the Tecnic Carbostent

06.09.2005


JUPITER II is an international multi-centre, double blind, randomized clinical trial designed to evaluate the safety and efficacy of JANUS Tacrolimus-eluting Carbostent in the treatment of coronary lesions in “direct stenting” procedures as compared to TECNIC Carbostent. A total of 332 patients were enrolled in 16 European centers and randomized to either JANUS (166 patients) or TECNIC (166 patients). Enrolment was completed on 21 December 2004 and direct stenting was performed in 86.1% of procedures for Tecnic group and in 75.9% of procedures for Janus group. The complete six-month clinical data (160 patients in Tecnic group and 157 patients in Janus group) clearly highlight strong clinical efficacy and safety.



The study reported stent related MACE of 10.6% (17 TLR out of 160 patients) for the control Tecnic group and a more favourable rate of 6.4% (9 TLR and 1 MI out of 157 patients) for Janus group (ns). The 6 month clinical efficacy of Janus stent is expressed by a 46% reduction in TLR in respect to Tecnic stent (TLR of 5.7% with Janus versus 10.6% with Tecnic). The occurrence of MACE in Jupiter II study is mainly related to TLR, the incidence of events such as death, AMI or CABG is negligible.

The Janus stent also exhibits a high level of safety, as demonstrated by 0% stent thrombosis rate (sub-acute and late) in both groups, confirming all previous clinical results with Tecnic and other Carbofilm coated stents.


Analysis of the angiographic follow-up data is almost completed and I will be delighted to present them at TCT in Washington,” commented Dr. Marie-Claude Morice. “The complete six-month clinical results of Jupiter II demonstrate the excellent clinical outcome and safety profile for the JANUS polymer-free drug-eluting stent technology, as demonstrated by the low MACE rate with Janus and a 46% reduction of TLR of versus Tecnic”.

Gina Dellios | alfa
Further information:
http://www.escardio.org/vpo/ESC_congress_information/ConferenceReleases/

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>